interventional clinical trials that were approved in the European Union (EU)/European Economic Area (EEA) under the Clinical Trials Directive 2001/20/EC
clinical trials conducted outside the EU/EEA that are linked to European paediatric-medicine development
EU/EEA interventional clinical trials approved under or transitioned to the Clinical Trial Regulation 536/2014 are publicly accessible through the
Clinical Trials Information System (CTIS).
The EU Clinical Trials Register currently displays
44341
clinical trials with a EudraCT protocol, of which
7370
are clinical trials conducted with subjects less than 18 years old.
The register also displays information on
18700
older paediatric trials (in scope of Article 45 of the Paediatric Regulation (EC) No 1901/2006).
Phase 1 trials conducted solely on adults and that are not part of an agreed paediatric investigation plan (PIP) are not publicly available (see
Frequently Asked Questions ).
4 result(s) found for: CGI-S and CGI-I Scales.' AnD sLeep(3) ANd '0'='0.
Displaying page 1 of 1.
EudraCT Number: 2014-004897-40
Sponsor Protocol Number: GABA-2
Start Date*: Information not available in EudraCT
Sponsor Name:PHARM – Pharmaceutical Research Management srl
Full Title: Randomized, double-blind, placebo controlled, multi-centre, superiority phase II study to evaluate the safety, pharmacokinetic, efficacy of gabapentin liquid formulation as add-on to morphine in ch...
Medical condition: Chronic pain of neuropathic or mixed origin
Disease:
Version
SOC Term
Classification Code
Term
Level
19.1
100000004852
10054095
Neuropathic pain
LLT
Population Age: Infants and toddlers, Children, Adolescents, Under 18
Sponsor Name:PHARM – Pharmaceutical Research Management srl
Full Title: Randomized, double-blind, double-dummy, active controlled, multicentre, non-inferiority phase-III study to compare the pharmacokinetic, efficacy and safety of gabapentin liquid formulation to trama...
Medical condition: Chronic pain of neuropathic or mixed origin
Disease:
Version
SOC Term
Classification Code
Term
Level
19.0
100000004852
10054095
Neuropathic pain
LLT
Population Age: Infants and toddlers, Children, Adolescents, Under 18
Sponsor Name:Takeda Development Center Americas, Inc.
Full Title: A Phase 4, Multicenter, 2-part Study Composed of a 1-Year Randomized,
Double-blind, Parallel-group, Placebo-controlled, Active-comparator,
Dose-optimization Evaluation followed by a 1-Year Open-lab...
Medical condition: Attention-deficit/hyperactivity disorder (ADHD)
Disease:
Version
SOC Term
Classification Code
Term
Level
23.0
100000004873
10064104
ADHD
LLT
Population Age: Children, Adolescents, Under 18
Gender: Male, Female
Trial protocol:DE(Ongoing)NL(Trial now transitioned)SE(Trial now transitioned)AT(Prematurely Ended)ES(Ongoing)BE(Trial now transitioned)PT(Prematurely Ended)GB(GB - no longer in EU/EEA)
Trial results:(No results available)
EudraCT Number: 2016-002171-94
Sponsor Protocol Number: Newrofeed
Start Date*: 2016-10-20
Sponsor Name:Mensia Technologies SA
Full Title: Effectiveness of a personalized Neurofeedback Training device (ADHD@Home) as compared with Methylphenidate in the treatment of children and adolescents with Attention-Deficit/Hyperactivity Disorder...
Medical condition: Attention Deficit-Hyperactivity Disorder
Subscribe to this Search
To subscribe to the RSS feed for this search click
here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options:
Number of Trials to download:
Download Content:
Download Format:
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial.
• EEA CTAs: Date study was authorised to proceed • Outside EU/EEA: Date study was submitted in EudraCT
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Query did not match any studies.
